Polypid Ltdis A Clinical Stage Biopharmaceutical Company Based In Petah Tikvaisraelfounded In 2008The Company Specializes In Developing And Commercializing Innovative Therapies Aimed At Improving Surgical Outcomesits Mission Is To Meet Unmet Medical Needs Through Its Proprietary Technology And Product Pipeline The Core Technology Of Polypid Is The Plexpolymer Lipid Encapsulation Matrixplatformwhich Enables Controlled And Continuous Medication Delivery Directly To Surgical Sitesthis Technology Allows For The Precise Release Of Active Pharmaceutical Ingredients Over Extended Periodstargeting Localized Medical Conditions Such As Infectionspaininflammationand Cancer Polypid S Lead Product Candidated Plex100Is Currently In A Pivotal Phase 3 Trial For Preventing Surgical Site Infections In Patients Undergoing Abdominal Colorectal Surgerythe Company Is Also Developing Oncoplex For Intra Tumoral Cancer Treatmentstarting With Glioblastomapolypid Collaborates With Pharmaceutical Companies To Enhance Local Medication Delivery And Has A Partnership With Immunogenesisincto Develop Formulations For Solid Tumors
No conferences found for this company.
| Company Name | Polypid Ltd |
| Country |
Israel
|
| Address | N/A |
| Telephone | N/A |
| N/A |
